Clicky

Incyte Corporation(INCY) News

Date Title
Jul 25 Incyte Corp (INCY) Price Target Hiked at UBS on Sales and Earnings Growth Prospects
Jul 24 Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025
Jul 24 Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
Jul 24 Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Jul 23 Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?
Jul 17 Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
Jul 16 INCY or TECH: Which Is the Better Value Stock Right Now?
Jul 14 India's Sun Pharma launches hair loss drug Leqselvi in US after patent settlement
Jul 11 High Growth Tech Stocks To Watch In US July 2025
Jul 10 Incyte’s Q2 2025 Earnings: What to Expect
Jul 9 William Blair Maintains ‘Hold’ Rating on Incyte Corporation (INCY), Citing Future Revenue Uncertainties
Jul 1 Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?
Jun 30 Jim Cramer Highlights That Incyte’s New CEO is an “Industry Veteran”
Jun 27 Incyte Stock Gets Relative Strength Rating Lift
Jun 27 Shell denies deal talks with BP, Micron reports Q3 beat: Morning Buzz
Jun 26 Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?
Jun 26 Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire
Jun 24 How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
Jun 23 FDA Extends INCY's Application for Opzelura Label Expansion
Jun 23 5 Revealing Analyst Questions From Incyte’s Q1 Earnings Call